JAK Mutations are genetic abnormalities that affect the production of red blood cells. They are often found in individuals with polycythemia vera, as well as a number of other myeloproliferative neoplasms. The anti-PD-1 agent, Keytruda (pembrolizumab) was approved in 2014 by the U.S. Food and Drug Administration for the treatment of advanced melanoma. Since then, it has received […]
Continue readingSkin Bacteria & Cancer New studies are showing that some bacteria in the skin have the potential to protect against skin cancer. A strain of S. epidermidis was revealed to produce a molecule that stops the growth of skin tumor on mice by killing cancer cells. According to a study published on February 28, […]
Continue readingPreclinical and Clinical Data Support Efficacy of Novel Approach to Cancer Immunotherapy Developed by CHIPSA Hospital CHIPSA Hospital, dedicated to the accelerated development of nontoxic cancer immunotherapies announced today filing of a patent application covering the combination of FDA approved antibodies known as “checkpoint inhibitors” together with Coley Vaccine, a stimulatory of innate immunity. CHIPSA […]
Continue readingTreatments against cancerous tumors have always been a dangerous and complicated process. These cancer cells can grow and spread rapidly. In addition, the current available treatments are determined by whether or not the patient can endure the treatment process, and also the location of the tumor. Scientists are now exploring Nano drugs. With the options […]
Continue readingThe study included oral and intravenous chemotherapy cancer drugs covered by Medicare Part B. Medicare is the federal health insurance plan for people 65 or older. “Higher costs lead to higher copays,” said study co-author Dr. Sham Mailankody. He’s a medical oncologist at Memorial Sloan Kettering Cancer Center in New York City. “And empiric research […]
Continue reading